Conferences Miltenyi Biomedicine is attending in 2026

miltenyibiomedicine.com

Miltenyi Biomedicine is listed at 2 conferences on Tnuki's calendar in 2026: BIO-Europe 2026 (on the program) and ASH 2026 (exhibiting). Miltenyi Biomedicine is a developer of cell and gene therapies, including CAR T-cell treatments, for cancer patients. As of Sep 29, 2026.

ConferenceDetailsInvolvementTnuki guide
BIO-Europe 2026European biotech partnering & BDOfficial site
Cologne, Germany ~5.8k attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 2 panel discussions, 1 talk
Attending
  • Government Affairs Lead, Europe
  • CEO
  • VP, Early Clinical Development and Translational Research
Attendee mix: Almost entirely industry; European biotech and pharma BD executives, licensing teams and investors
Open the guide Search and filter attendees
ASH 2026 Annual Meeting & ExpositionHematologists & blood cancer researchersOfficial site
New Orleans, LA ~30k attendees ExhibitorAs published by American Society of Hematology
Booth 3213Program 1 symposium
Attendee mix: Mostly clinical; hematologists, KOLs, hematologic-oncology researchers, medical affairs and cell-therapy biopharma teams
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 29 of the 90 conferences on our calendar, so this page shows Miltenyi Biomedicine’s involvement at those 29 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Miltenyi Biomedicine

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →